Serum ferritin is elevated in amyotrophic lateral sclerosis patients

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 16, Issue 1-2, 2015, Pages 102-107

  Su, Xiaowei W ^a   Clardy, Stacey L ^a   Stephens, Helen E ^a   Simmons, Zachary ^a   Connor, James R ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Iron metabolism; Neurological disease control; Serum ferritin; Survival

Indexed keywords

FERRITIN; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; DEATH; FEMALE; FERRITIN BLOOD LEVEL; GENOTYPE; HUMAN; IMMUNOASSAY; IRON METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; BLOOD; GENETICS; MIDDLE AGED; MORTALITY; MUTATION; NONPARAMETRIC TEST; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; FERRITINS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84925675033     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2014.984723     Document Type: Article

References (27)

1. Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci. 2013; 14: 248-64.
2. Nandar W, Connor JR. HFE gene variants affect iron in the brain. J Nutr. 2011; 141: S729-39.
3. Wang XS, Lee S, Simmons Z, Boyer P, Scott K, Liu W, et al. Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences. J Neurol Sci. 2004; 227: 27-33.
4. Goodall EF, Greenway MJ, van Marion I, Carroll CB, Hardiman O, Morrison KE. Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS. Neurology. 2005; 65: 934-7.
5. Restagno G, Lombardo F, Ghiglione P, Calvo A, Cocco E, Sbaiz L, et al. HFE H63D polymorphism is increased in patients with amyotrophic lateral sclerosis of Italian origin. J Neurol Neurosurg Psychiatry. 2007; 78: 327.
6. Sutedja NA, Sinke RJ, van Vught PW, van der Linden MW, Wokke JH, van Duijn CM, et al. The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population. Arch Neurol. 2007; 64: 63-7.
7. He X, Lu X, Hu J, Xi J, Zhou D, Shang H, et al. H63D polymorphism in the hemochromatosis gene is associated with sporadic amyotrophic lateral sclerosis in China. Eur J Neurol. 2011; 18: 359-61.
8. Praline J, Blasco H, Vourc'h P, Rat V, Gendrot C, Camu W, et al. Study of the HFE gene common polymorphisms in French patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci. 2012; 317: 58-61.
9. van Rheenen W, Diekstra FP, van Doormaal PT, Seelen M, Kenna K, McLaughlin R, et al. H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis. Neurobiol Aging. 2013; 34: 1517, e5-7.
10. Liu Y, Lee SY, Neely E, Nandar W, Moyo M, Simmons Z, et al. Mutant HFE H63D protein is associated with prolonged endoplasmic reticulum stress and increased neuronal vulnerability. J Biol Chem. 2011; 286: 13161-70.
11. Nandar W, Neely EB, Unger E, Connor JR. A mutation in the HFE gene is associated with altered brain iron profiles and increased oxidative stress in mice. Biochim Biophys Acta. 2013; 1832: 729-41.
12. Qureshi M, Brown RH Jr, Rogers JT, Cudkowicz ME. Serum ferritin and metal levels as risk factors for amyo-trophic lateral sclerosis. Open Neurol J. 2008; 2: 51-4.
13. Goodall EF, Haque MS, Morrison KE. Increased serum fer-ritin levels in amyotrophic lateral sclerosis patients. J Neurol. 2008; 255: 1652-6.
14. Ikeda K, Hirayama T, Takazawa T, Kawabe K, Iwasaki Y. Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study. Intern Med. 2012; 51: 1501-8.
15. Nadjar Y, Gordon P, Corcia P, Bensimon G, Pieroni L, Meininger V, et al. Elevated serum ferritin is associated with reduced survival in amyotrophic lateral sclerosis. PLoS One. 2012; 7: e45034.
16. Mitchell RM, Simmons Z, Beard JL, Stephens HE, Connor JR. Plasma biomarkers associated with ALS and their relationship to iron homeostasis. Muscle Nerve. 2010; 42: 95-103.
17. Su XW, Simmons Z, Mitchell RM, Kong L, Stephens HE, Connor JR. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis. JAMA Neurol. 2013; 70: 1505-11.
18. Danzeisen R, Achsel T, Bederke U, Cozzolino M, Crosio C, Ferri A, et al. Superoxide dismutase-1 modulates expression of transferrin receptor. J Biol Inorg Chem. 2006; 11: 489-98.
19. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 293-9.
20. Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: past, present and future. Biochim Biophys Acta. 2010; 1800: 760-9.
21. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood. 2002; 99: 3505-16.
22. Barber SC, Shaw PJ. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med. 2010; 48: 629-41.
23. Joshi JG, Sczekan SR, Fleming JT. Ferritin: a general metal detoxicant. Biol Trace Elem Res. 1989; 21: 105-10.
24. Olsen MK, Roberds SL, Ellerbrock BR, Fleck TJ, McKinley DK, Gurney ME. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann Neurol. 2001; 50: 730-40.
25. Greenwood DI. Nutrition management of amyotrophic lateral sclerosis. Nutr Clin Pract. 2013; 28: 392-9.
26. Molfino A, Kushta I, Tommasi V, Rossi Fanelli F, Muscaritoli M. Amyotrophic lateral sclerosis, enteral nutrition and the risk of iron overload. J Neurol. 2009; 256: 1015-6.
27. Lee SY, Patton SM, Henderson RJ, Connor JR. Consequences of expressing mutants of the hemochromatosis gene (HFE) into a human neuronal cell line lacking endogenous HFE. FASEB J. 2007; 21: 564-76.